In our analysis we estimated the cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland, based on data from a pilot study. We found that a national screening programme would be expensive to implement nationally and would not be deemed cost-effective by policy makers in Ireland.
Gillespie P, O’Neill C, Adams E, et al. Cost effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland. Sex Transm Infect 2012; 88:3, 222-228. doi:10.1136/sextrans-2011-050067